Medline Inc. vs Eli Lilly & Co.
MDLN vs LLY — side-by-side comparison from reported financials. MDLN leads 1, LLY leads 9 of 10 comparable metrics.
Medline Inc.
MDLN · Healthcare
$36.29+1.54%Solid
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | MDLN | LLY |
|---|---|---|
| Price | $36.29 | $1 177.20 |
| Market cap | $31.8B | $1.05T |
| Revenue (TTM) | $29.9B | $79.7B |
| Revenue growth | +9.8% | +31.7% |
| Net margin | 1.7% | 33.5% |
| Free cash flow | $1.58B | $18.2B |
| Net cash (debt) | ($10.6B) | ($35.2B) |
| 1-year price return | — | +37.6% |
| P/E | 68.8 | 41.6 |
| P/E vs own history (cheap-side %) | 15% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | 5% | 93% |
| Altman Z-score | 1.65 | 7.10 |
| CV checks passed | 5 of 10 | 11 of 10 |
| Employees | 45,000 | 50,000 |
Full résumé-style profiles: MDLN CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.